Paul C. Gordon, M.D.’s research interests include evaluating therapies and novel devices for coronary and structural heart disease. His current research focuses on transcatheter aortic valves with projects such as Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) and Edoxaban versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation-in Atrial Fibrillation. His other research project is on Physiologic Assessment of Coronary Stenosis Following PCI (DEFINE PCI).
Studies currently enrolling
ENVISAGE - Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation – In Atrial Fibrillation.
VIVIO - Assessment of the Vivio System as an Aid in the Identification of Heart Sounds Associated with Severe Aortic Stenosis
TAVR UNLOAD - Transcatheter Aortic Valve Replacement to Unload the Left Ventricle in Patients with Advenced Heart Failure: A Randomized (TAVR UNLOAD)
TROPONIN I - Troponin I Specimen Collection. The primary objective of this protocol is to collect paired serum and lithium heparin plasma samples with different Troponin I (TnI) levels to conduct a sample stability study.